MSA
ASMB icon

Marino Stram & Associates’s Assembly Biosciences ASMB Stock Holding History

Marino Stram & Associates’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8
Closed -$2K – 114
2019
Q1 		$2K Sell
8
-3
-27% -$760 ﹤0.01% 511
2018
Q4 		$3K Hold
11
– – ﹤0.01% 390
2018
Q3 		$5K Hold
11
– – ﹤0.01% 347
2018
Q2 		$5K Hold
11
– – ﹤0.01% 342
2018
Q1 		$6K Hold
11
– – 0.01% 356
2017
Q4 		$6K Buy
+11
New +$4.98K 0.01% 357

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Marino Stram & Associates's ASMB Position: Q2 2019 in Review

Marino Stram & Associates sold out of Assembly Biosciences (ASMB) in Q2 2019, closing a stake of 8 shares — an estimated $2K sold.

Marino Stram & Associates first reported a position in ASMB in Q4 2017 and held it in 6 quarters. The position peaked at $6K in Q1 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2019.

  • Marino Stram & Associates reported no remaining Assembly Biosciences position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 8 Assembly Biosciences shares in Q2 2019, an estimated $2K.
  • Marino Stram & Associates first reported a position in Assembly Biosciences in Q4 2017 and held it in 6 quarters.
  • Marino Stram & Associates's Assembly Biosciences position peaked at $6K in Q1 2018.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.